Canine Parvovirus Vaccine – Modified Live Virus


Core Disease Protection
Induces protection against the most lethal and prevalent viral disease of dogs, canine parvovirus

Maximum Protection
Contains a High Antigen Mass (more vaccine units per dose) which results in:
- Short period from vaccination to protection
- Higher level of protection (many times greater than the level needed for basic protection)
- Long duration of immunity

Early Age Protection
Stimulates antibody production in the presence of existing maternal antibodies

First Dose Protection
- Antibody production begins after the first dose. Other canine parvovirus vaccines require two or three doses to stimulate an initial antibody response.

Single Antigen Vaccine
- Eliminates the need to use complex combination adult vaccines (commonly referred to as 5-way vaccines) in the young puppy
- More efficient in stimulating antibody production than complex combination vaccines

- Found to be safe for use in young puppies
- Less likely to produce a vaccine reaction than complex combination vaccines

Convenient Packaging
- Packaged in a 10 dose vial or a carton of 25 single dose vials of vaccine

Material Safety Data Sheet: Click here to download pdf.

Here is a picture of the label:

label neopar


View the embedded image gallery online at: